The effect of infliximab therapy on spinal inflammation assessed by magnetic resonance imaging in a randomized, placebo-controlled trial of 279 patients with ankylosing spondylitis

被引:0
|
作者
Van der Heijde, D
Landewe, R
Hermann, K
Han, J
Williamson, P
Braun, J
机构
[1] Univ Hosp Maastricht, Dept Rheumatol, Maastricht, Netherlands
[2] Charite, Dept Radiol, Berlin, Germany
[3] Centocor Inc, Clin Res, Malvern, PA USA
[4] Rheumazentrum Ruhrgebiet, Herne, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:317 / 317
页数:1
相关论文
共 50 条
  • [1] The effect of infliximab therapy on spinal inflammation assessed by magnetic resonance imaging in a randomized, placebo-controlled trial of 279 patients with ankylosing spondylitis.
    Braun, R
    Landewé, R
    Hermann, KG
    Damaraju, L
    Williamson, P
    van der Heijde, D
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4104 - 4105
  • [2] Improvement of spinal inflammation in Ankylosing spondylitis (AS) by infliximab therapy as assessed by a magnetic resonance Imaging (MRI) using a novel evaluated spinal scoring system - Results of a double-blind placebo-controlled trial.
    Braun, J
    Baraliakos, X
    Golder, W
    Listing, J
    Brandt, J
    Bollow, M
    Sieper, J
    van der Heijde, D
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S426 - S427
  • [3] Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study
    Maksymowych, Walter P.
    Salonen, David
    Inman, Robert D.
    Rahman, Proton
    Lambert, Robert G. W.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1728 - 1734
  • [4] Effect of infliximab on markers of inflammation and angiogenesis and correlations with improvement in spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis.
    Visvanathan, S
    Braun, J
    van der Heijde, D
    Marini, JC
    Han, J
    Gathany, T
    Wagner, C
    Williamson, P
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S279 - S279
  • [5] Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab -: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study
    Braun, J
    Landewé, R
    Hermann, KGA
    Han, J
    Yan, S
    Williamson, P
    van der Heijde, D
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1646 - 1652
  • [6] Efficacy and safety of infliximab in patients with ankylosing spondylitis - Results of a randomized, placebo-controlled trial (ASSERT)
    van der Heijde, D
    Dijkmans, B
    Geusens, P
    Sieper, J
    DeWoody, K
    Williamson, P
    Braun, K
    Breban, M
    Burmester, G
    Clark, M
    Deadhar, A
    Douga-dos, M
    Edwards, W
    Gaston, J
    Inman, R
    Kellner, H
    Leirisalo-Repo, M
    Maksymowych, W
    Moreland, L
    Peloso, P
    Reveille, J
    Ritchlin, C
    Schneider, M
    Smith, D
    Steinfeld, S
    Veys, E
    de Vlam, K
    Zeidler, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 582 - 591
  • [7] Infliximab improves productivity in employed patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (assert)
    Van der Heijde, D
    DeVlam, K
    Burmester, G
    Veys, E
    Han, C
    DeWoody, K
    Williamson, P
    Bala, M
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 400 - 400
  • [8] Infliximab improves quality of life in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)
    Braun, J
    Kellner, H
    Deodhar, A
    Inman, R
    Han, C
    DeWoody, K
    Williamson, P
    Bala, M
    van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 402 - 402
  • [9] Infliximab improves fatigue and pain in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)
    Van der Heijde, D
    Han, C
    Bala, M
    Williamson, P
    Han, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 318 - +
  • [10] Infliximab improves fatigue and pain in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial.
    van der Heijde, D
    Han, CL
    Bala, M
    Williamson, P
    Han, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S35 - S35